Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology (Q26998471)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology	scientific article

Statements

scholarly article

1 reference

1 reference

21 March 2019

Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology (English)

0 references

fatty liver disease

1 reference

21 March 2019

metabolic disease

1 reference

21 March 2019

1 reference

PubMed publication ID

medical guideline

1 reference

PubMed publication ID

1 reference

PubMed publication ID

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Xin Gao

1

1 reference

Jian-Gao Fan

2

1 reference

language of work or name

1 reference

publication date

December 2013

1 reference

1 December 2013

1 reference

21 March 2019

Journal of diabetes

2 references

21 March 2019

5

1 reference

4

1 reference

406-15

1 reference

copyright license

Creative Commons Attribution 3.0 Unported

1 reference

Europe PubMed Central

21 March 2019

copyright status

0 references

on focus list of Wikimedia project

0 references

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

21 March 2017

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

21 March 2017

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

21 March 2017

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

21 March 2017

Standards of medical care in diabetes--2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

Nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

7 April 2017

The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Nonalcoholic fatty liver disease and vascular risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Noninvasive assessment of hepatic steatosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Diagnosis and therapy of nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Non-alcoholic fatty liver disease: the mist gradually clears

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Treatment modalities of obesity: what fits whom?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Managing nonalcoholic fatty liver disease: recommendations for family physicians.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Clinical use of carotid intima-media thickness: review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

GI epidemiology: nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 September 2017

Nonalcoholic fatty liver disease in Asia: a story of growth

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Fatty liver and the metabolic syndrome among Shanghai adults

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12056

21 January 2018

Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 November 2018

[Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 November 2018

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933762

28 November 2018

American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of conventional serum autoantibodies for various liver diseases in a Chinese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interobserver and intraobserver variability in the sonographic assessment of fatty liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of iron in nonalcoholic fatty liver disease: the story continues

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23560695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/1753-0407.12056

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26998471&oldid=1588089891"